Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC

Predictors of longer postdiscontinuation progression-free survival include complete/partial response, longer treatment duration
immunotherapy
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com